Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-up Study for Patients Having Received FluBHPVE6E7 in Clinical Studies

NCT04528407 is registered in ClinicalTrials.gov with BlueSky Immunotherapies GmbH as lead sponsor.

NCT NCT04528407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04528407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-up Study for Patients Having Received FluBHPVE6E7 in Clinical Studies
Lead sponsor
BlueSky Immunotherapies GmbH
Phase
Observational
Overall status
Completed
Start date
April 9, 2021
Completion date
January 31, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infection, safety issues